Core Scientific: DuChene trust proposes $2.16M sale

The trust's listed prior sales were each 10,000 shares under 10b5-1, with dates spanning July 13 through October 5, 2026.

Rhea-AI Filing Summary

Core Scientific, Inc. common stock is the subject of a proposed sale of 140,000 shares for the account of the Todd DuChene Revocable Trust, with an aggregate market value of $2,157,400.00. Morgan Stanley Smith Barney LLC is named as broker and NASDAQ as the sale venue. Todd DuChene is identified as an officer. The notice also lists prior sales by the trust under 10b5-1, including 10,000 shares on October 5, 2026.

Key Figures

Shares listed for sale: 140,000 shares Aggregate market value: $2,157,400.00 Shares outstanding: 321,340,441 shares

3 metrics

Shares listed for sale 140,000 shares Proposed sale for the Todd DuChene Revocable Trust

Aggregate market value $2,157,400.00 Value listed for the proposed sale

Shares outstanding 321,340,441 shares Figure listed in the securities information

Key Terms

Rule 144, 10b5-1 Sales

2 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 Sales regulatory

"10b5-1 Sales for TODD DUCHENE REVOCABLE TRUST"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CORZ shares are listed for sale by the Todd DuChene Revocable Trust?

The notice lists 140,000 shares of Core Scientific, Inc. common stock for sale for the trust, with an aggregate market value of $2,157,400.00. Morgan Stanley Smith Barney LLC is listed as broker, and NASDAQ as the sale venue.

What prior CORZ sales are listed for the Todd DuChene Revocable Trust?

The listed prior sales are 10,000 shares each under 10b5-1, with transaction dates ranging from July 13 through October 5, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 08:21 AM EDT Accepted by SEC EDGAR 10/13/2026 - 08:21 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001248745
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Core Scientific, Inc.
SEC File Number	001-40046
Address of Issuer	838 Walker Road Suite 21-2105 Dover DELAWARE 19904
Phone	512-402-5233
Name of Person for Whose Account the Securities are To Be Sold	TODD DUCHENE REVOCABLE TRUST
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	140000	2157400.00	321340441	10/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/13/2024	Tender	Issuer			140000	12/13/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for TODD DUCHENE REVOCABLE TRUST 838 Walker Road Suite 21-2105 Dover DE 19904	Common	10/05/2026	10000	163056.00
10b5-1 Sales for TODD DUCHENE REVOCABLE TRUST 838 Walker Road Suite 21-2105 Dover DE 19904	Common	09/28/2026	10000	167586.00
10b5-1 Sales for TODD DUCHENE REVOCABLE TRUST 838 Walker Road Suite 21-2105 Dover DE 19904	Common	09/21/2026	10000	183746.00
10b5-1 Sales for TODD DUCHENE REVOCABLE TRUST 838 Walker Road Suite 21-2105 Dover DE 19904	Common	09/14/2026	10000	171362.00
10b5-1 Sales for TODD DUCHENE REVOCABLE TRUST 838 Walker Road Suite 21-2105 Dover DE 19904	Common	09/08/2026	10000	186735.00
10b5-1 Sales for TODD DUCHENE REVOCABLE TRUST 838 Walker Road Suite 21-2105 Dover DE 19904	Common	08/31/2026	10000	162340.00
10b5-1 Sales for TODD DUCHENE REVOCABLE TRUST 838 Walker Road Suite 21-2105 Dover DE 19904	Common	08/24/2026	10000	174493.00
10b5-1 Sales for TODD DUCHENE REVOCABLE TRUST 838 Walker Road Suite 21-2105 Dover DE 19904	Common	08/17/2026	10000	200974.00
10b5-1 Sales for TODD DUCHENE REVOCABLE TRUST 838 Walker Road Suite 21-2105 Dover DE 19904	Common	08/10/2026	10000	199736.00
10b5-1 Sales for TODD DUCHENE REVOCABLE TRUST 838 Walker Road Suite 21-2105 Dover DE 19904	Common	08/03/2026	10000	222340.00
10b5-1 Sales for TODD DUCHENE REVOCABLE TRUST 838 Walker Road Suite 21-2105 Dover DE 19904	Common	07/27/2026	10000	209477.00
10b5-1 Sales for TODD DUCHENE REVOCABLE TRUST 838 Walker Road Suite 21-2105 Dover DE 19904	Common	07/20/2026	10000	222995.00
10b5-1 Sales for TODD DUCHENE REVOCABLE TRUST 838 Walker Road Suite 21-2105 Dover DE 19904	Common	07/13/2026	10000	224475.00

144: Remarks and Signature

Remarks	Sales that were executed on October 12, 2026 are being reported on this Form 144 filed on October 13, 2026 given the EDGAR system was not accepting filings on October 12, 2026 in observance of the federal holiday.
Date of Notice	10/12/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/05/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Todd DuChene
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)